Bessemer Group’s Verona Pharma VRNA Stock Holding History

Bessemer Group’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-190	Closed	-$20K	–	2723
2025 Q3	$20K	Buy	190 +100	+111%	+$10.4K	﹤0.01%	1701
2025 Q2	$9K	Buy	+90	New	+$6.66K	﹤0.01%	1874

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Bessemer Group's VRNA Position: Q4 2025 in Review

Bessemer Group sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 190 shares — an estimated $20K sold.

Bessemer Group first reported a position in VRNA in Q2 2025 and held it in 2 quarters. The position peaked at $20K in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Bessemer Group reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Bessemer Group sold 190 Verona Pharma shares in Q4 2025, an estimated $20K.
Bessemer Group first reported a position in Verona Pharma in Q2 2025 and held it in 2 quarters.
Bessemer Group's Verona Pharma position peaked at $20K in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Bessemer Group's 13F filing for Q4 2025, filed 5 Feb 2026.